Robert Kiyosaki warns the biggest financial crash in history is imminent, and only precious metals and Bitcoin can protect investors during the market upheaval.
Author: techrossm
Ethereum Price Attempts 3 Rebounds in 10 Days — Charts Explain Why Each Failed
Ethereum price has attempted three rebounds in 10 days but keeps failing near $2,000. Key charts explain the core reason.
Tron defies crypto market slump as Bitcoin, Ethereum lead $221M liquidation wave
TRON was the only major token to rise, up by 0.06%, while most other large-cap coins stayed in the bearish sentiment. ・In the broader
Rich Dad Poor Dad author predicts giant market crash, remains bullish on Bitcoin
In a post on social media platform X, Kiyosaki said that the crash he had warned about in theRich Dad’s Prophecy published in 2013
Gold, Silver ETFs: From taxation to expense ratio – All you need to know before investing
Gold and Silver ETFs provide a way to invest in precious metals without physical storage. However, investors must consider taxation, expense ratios, price volatility,
From AI hype to AI fear: Why tech stocks are losing ground in 2026
Backlash: Big tech stocks are down since the start of the year. Wall Street is concerned about the disruptive potential.
3 Big New Reasons to Be Bullish About XRP (Ripple) in 2026 and Beyond
Here are three of the most important new features, each of which is a fresh reason to be bullish about the coin for the
Bitcoin Price Today Consolidates Near $69,000 While Dogecoin, Solana See Sharp Losses; ETH Slides Below $2,000
Bitcoin price today was hovering around $68,770, with a decline of roughly 2% over the recent session. Despite the dip, the tokens market value
Global investors stay ‘uber-bullish’ but warn companies are overinvesting
MILAN, Feb 17 – Global investors are increasingly worried that companies are overinvesting, just as market sentiment remains “uber‑bullish” and further asset gains look
Vertex Pharmaceuticals stock: Is Wall Street bullish or bearish?
Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology firm that discovers, develops, and commercializes transformative medicines for serious diseases, with a particular focus on